These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12162444)

  • 1. Arsenic carcinogenicity: relevance of c-Src activation.
    Simeonova PP; Luster MI
    Mol Cell Biochem; 2002; 234-235(1-2):277-82. PubMed ID: 12162444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
    Simeonova PP; Luster MI
    J Environ Pathol Toxicol Oncol; 2000; 19(3):281-6. PubMed ID: 10983894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by arsenic. Role in carcinogenesis.
    Simeonova PP; Wang S; Hulderman T; Luster MI
    J Biol Chem; 2002 Jan; 277(4):2945-50. PubMed ID: 11723127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor.
    Gao Y; Tang S; Zhou S; Ware JA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):426-33. PubMed ID: 11160627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two modes of ERK activation by TNF in keratinocytes: different cellular outcomes and bi-directional modulation by vitamin D.
    Ziv E; Rotem C; Miodovnik M; Ravid A; Koren R
    J Cell Biochem; 2008 May; 104(2):606-19. PubMed ID: 18080320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production.
    Cooper KL; Myers TA; Rosenberg M; Chavez M; Hudson LG
    Toxicol Appl Pharmacol; 2004 Nov; 200(3):177-85. PubMed ID: 15504454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncogenic activation of p21(ras) and pp60(c-src) in human colonic Caco-2 cells decreases insulin receptor function and expression through protein kinase C-dependent and independent pathways].
    Baron-Delage S; Barbu V; Bertrand F; Chastre E; Lévy P; Gespach C; Capeau J; Cherqui G
    Bull Cancer; 1994 Oct; 81(10):882-5. PubMed ID: 7734771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of protein tyrosine kinase pp60v-src variants in Dictyostelium discoideum.
    Brábek J; Mojzita D; Půta F
    Folia Biol (Praha); 2002; 48(2):73-6. PubMed ID: 12002678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of c-Src activity by the expression of wild-type v-Src and its kinase-dead double Y416F-K295N mutant.
    Vojtechová M; Senigl F; Sloncová E; Tuhácková Z
    Arch Biochem Biophys; 2006 Nov; 455(2):136-43. PubMed ID: 17056000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic.
    Sung TI; Wang YJ; Chen CY; Hung TL; Guo HR
    Sci Total Environ; 2012 May; 424():74-8. PubMed ID: 22446113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
    Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
    Brickell PM
    Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
    Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential.
    Mao W; Irby R; Coppola D; Fu L; Wloch M; Turner J; Yu H; Garcia R; Jove R; Yeatman TJ
    Oncogene; 1997 Dec; 15(25):3083-90. PubMed ID: 9444956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos.
    Scapoli L; Ramos-Nino ME; Martinelli M; Mossman BT
    Oncogene; 2004 Jan; 23(3):805-13. PubMed ID: 14737115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor.
    Alexander LD; Ding Y; Alagarsamy S; Cui XL; Douglas JG
    Kidney Int; 2006 May; 69(10):1823-32. PubMed ID: 16598196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
    Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
    Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway.
    Ye YN; Liu ES; Shin VY; Wu WK; Luo JC; Cho CH
    J Pharmacol Exp Ther; 2004 Jan; 308(1):66-72. PubMed ID: 14569062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.